An Alzheimer's biomarker blood test during middle age may help doctors detect very early signs of cognitive decline to help ...

Alzheimer disease neuropathology is associated with worse cognitive performance, according to a study published in the May 30 ...

Exercise interventions show distinct cognitive benefits for patients with Alzheimer disease or mild cognitive impairment, but ...

Almost 50 more genes have been flagged as being linked to Alzheimer’s, along with changes in activity in crucial cells that ...

Eisai Inc. today announced the expansion of its Magnolia Meals at Home® program to support the Alzheimer's disease and ...

Two new tool compounds may help scientists study TAOK proteins linked to Alzheimer’s disease and other neurological disorders. Alzheimer’s disease is the leading cause of dementia and affects more ...

Alzheimer's disease is a neurodegenerative disease characterized by a progressive decline in mental functions and memory loss. Along with frontotemporal dementia and some other neurodegenerative ...

For the first time, researchers found blood biomarkers for Alzheimer's disease that correlated with minor cognitive ...

The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein called amyloid-β was responsible for memory loss in Alzheimer’s disease. On its ...

The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major milestone for patients.

Reviewed by Anton Porsteinsson, MD, Director of the University of Rochester Alzheimer’s Disease Care, Research and Education Program (AD-CARE) in New York; and the first William B. and Sheila Konar, ...

More than 520,000 Britons have Alzheimer's - the most common form of dementia, which is the leading cause of death in UK.